SCHEMBL10089714

SCHEMBL10089714

[3H]CB

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10019339 0.83
SCHEMBL10019340 0.83
SCHEMBL14268554 0.72
SCHEMBL85457 0.71
SCHEMBL9505413 0.61
Phosphine SCHEMBL13723818 0.61
SCHEMBL7795632 0.61
SCHEMBL6731352 0.61
SCHEMBL8971061 0.61
Hydrogen Sulfide SCHEMBL9164199 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680049-B2 Glucagon analogues ZEALAND PHARMA A/S (DK) 2014-03-25 US disclosed
US-20140080757-A1 GLUCAGON ANALOGUES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-20 US disclosed
US-20140051860-A1 PROCESS FOR PRODUCING A NITROGEN-CONTAINING CARBON ALLOY FUJIFILM CORPORATION (JP) 2014-02-20 US disclosed
US-8642541-B2 Glucagon analogues ZEALAND PHARMA A/S (DK) 2014-02-04 US disclosed
US-8642540-B2 Glucagon analogues ZEALAND PHARMA A/S (DK) 2014-02-04 US disclosed
US-8586201-B2 Light-emitting element and iridium complex CHIMEI INNOLUX CORPORATION (TW) 2013-11-19 US disclosed
US-20130287699-A1 Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2013-10-31 US disclosed
US-8512869-B2 Silicon composition and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-08-20 US disclosed
US-20130157953-A1 TREATMENT OF CARDIAC CONDITIONS ZEALAND PHARMA A/S (DK) 2013-06-20 US disclosed
US-20130157935-A1 GLUCAGON ANALOGUES ZEALAND PHARMA A/S (DK) 2013-06-20 US disclosed
US-20090036718-A1 USE OF A COMPOSITION OF AN IONIC NATURE AS A SUBSTITUTION REAGENT, A COMPOSITION CONSTITUTING A FLUORINATION REAGENT AND A METHOD USING SAME RHODIA CHIMIE (FR) 2009-02-05 US disclosed
US-20080217606-A1 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2008-09-11 US disclosed
US-20080194886-A1 CATALYSTS FOR NUCLEOPHILIC SUBSTITUTION, SYNTHESIS THEREOF, COMPOSITION CONTAINING THEM AND USE THEREOF RHODIA CHIMIE (FR) 2008-08-14 US disclosed
US-20080176105-A1 Heterocycle-containing organometallic complex and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2008-07-24 US disclosed
US-7393980-B2 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same RHODIA CHIMIE (FR) 2008-07-01 US disclosed
US-20070249596-A1 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. 2007-10-25 US disclosed
US-20070225524-A1 Catalysts for nucleophilic substitution, synthesis thereof, composition containing them and use thereof SCHANEN VINCENT 2007-09-27 US disclosed
US-20070141394-A1 LIGHT-EMITTING ELEMENT AND IRIDIUM COMPLEX CHI MEI OPTOELECTRONICS CORP. (TW) 2007-06-21 US disclosed
US-7217842-B2 Catalysts for nucleophilic substitution, synthesis thereof, composition containing them and use thereof RHODIA-CHIMIE (FR) 2007-05-15 US disclosed
US-20070049645-A1 Anti-nausea and anti-vomiting activity of cannabidiol compounds YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2007-03-01 US disclosed